Silgan Q3 2026 Earnings: Adjusted EPS Rises as GAAP Profit Falls
Silgan reported Q3 2026 net sales of $2.04 billion, a 2% year-over-year increase driven primarily by raw-material cost pass-throughs rather than volume growth. While GAAP diluted EPS fell 7% to $0.99 due to rising rationalization and acquisition-related costs and a higher tax rate, adjusted diluted EPS rose 7% to $1.31. Adjusted EBIT and EBITDA improved across Metal and Custom Containers. Management raised the lower end of its full-year adjusted EPS range to $3.83–$3.93 and reaffirmed free cash flow at approximately $450 million. Key investor risks include persistent volume declines, price-cost recovery lags, and fourth-quarter working-capital conversion.
Silgan (NYSE: SLGN) reported Q3 2026 net sales of $2.04 billion, up 2% from $2.01 billion a year earlier, while GAAP diluted EPS fell to $0.99 from $1.06. Adjusted diluted EPS increased 7% to $1.31, but muted volume trends and higher rationalization and acquisition-related costs created a clear gap between adjusted and GAAP profitability.
Core Financial Results
Revenue increased primarily because Silgan passed through higher raw-material costs under customer contracts, rather than because of broad volume growth. Gross profit was nearly unchanged, while GAAP EBIT and net income declined.
On an adjusted basis, the picture was better: adjusted EBIT rose about 6% and adjusted EBITDA increased 5%, reflecting improved results in Metal Containers and Custom Containers.
| Metric | Q3 2026 | Q3 2025 | Year-over-Year Change |
|---|---|---|---|
| Net sales | $2,040.2 million | $2,008.7 million | +2% |
| Gross profit / margin | $328.6 million / 16.1% | $327.3 million / 16.3% | +0.4%; margin down about 0.2 points |
| GAAP EBIT / margin | $191.7 million / 9.4% | $198.7 million / 9.9% | Down about 4%; margin down about 0.5 points |
| Net income | $105.0 million | $113.3 million | Down about 7% |
| GAAP diluted EPS | $0.99 | $1.06 | Down about 7% |
| Adjusted diluted EPS | $1.31 | $1.22 | +7% |
| Adjusted EBIT | $235.0 million | $221.4 million | +6% |
| Adjusted EBITDA | $302.8 million | $288.3 million | +5% |
Adjusted EPS, adjusted EBIT, and adjusted EBITDA are non-GAAP measures. Q3 2026 adjusted EPS excluded $0.32 per share of specified items, compared with $0.16 per share a year earlier.
Business and Segment Performance
Segment results showed meaningful differences. Metal Containers generated the largest adjusted profit improvement despite lower volume, while Dispensing and Specialty Closures recorded flat overall volume and lower adjusted EBIT. Custom Containers also improved adjusted profit even as volumes declined.
| Segment | Net Sales and YoY Change | Adjusted EBIT and YoY Change | Main Operating Trend |
|---|---|---|---|
| Dispensing and Specialty Closures | $699.2 million, +1% | $111.2 million, -2% | Overall volume was flat; pharma dispensing grew by double digits and fragrance dispensing by mid-single digits, offset by softer food and beverage closures demand |
| Metal Containers | $1,174.2 million, +1% | $105.2 million, +10% | Volume fell 4%, but favorable price-cost and mix more than supported adjusted profit growth |
| Custom Containers | $166.8 million, +4% | $23.7 million, +3% | Volume fell 8%, including about three percentage points from exiting lower-margin business; pricing, mix, and cost reductions supported profit |
In Dispensing and Specialty Closures, delayed recovery of manufacturing inflation, freight, and applicable surcharges contributed to less favorable price-cost performance. Manufacturing efficiency was also weaker. Metal Containers benefited from higher fruit and vegetable and pet food volumes, but those gains did not offset lower soup-market shipments.
Higher Adjustments Split GAAP and Adjusted Profit Trends
Silgan’s adjusted operating profit increased while GAAP operating profit declined because the adjustments were substantially larger than a year ago. Rationalization charges rose to $17.1 million from $7.2 million, while costs attributed to announced acquisitions were $10.3 million compared with none in Q3 2025.
Total pre-tax adjustments increased to $42.5 million from $21.9 million. As a result, the adjustment to diluted EPS doubled to $0.32 from $0.16. The higher effective tax rate—27.9% versus 24.3%—also contributed to the decline in GAAP net income.
Profitability, Cash Flow, and Balance Sheet
Corporate expense increased to $15.4 million from $11.0 million, primarily because of corporate development costs. Interest and other debt expense declined to $47.3 million from $50.0 million due to lower weighted-average borrowings, partially offsetting other pressures.
Cash flow figures were provided for the first nine months rather than Q3 alone. Net cash used in operating activities was $646.4 million, compared with $564.0 million in the prior-year period. The largest use was a $1.05 billion increase in trade receivables, while inventory changes provided $152.9 million of cash. Nine-month capital expenditures were $229.5 million, down from $235.8 million.
Cash and cash equivalents stood at $325.0 million on September 30, down from $1.08 billion at the end of 2025. Debt was $4.55 billion, up from $4.35 billion at year-end but below $4.95 billion one year earlier. Given the company’s confirmed full-year free cash flow target, fourth-quarter working-capital conversion remains an important point to monitor.
Guidance
Silgan raised the lower end of its full-year adjusted EPS range while leaving the upper end unchanged. This increased the midpoint by $0.05 to $3.88. The company also reaffirmed its free cash flow estimate and expects adjusted EBIT to exceed 2025 levels in every segment.
| Metric | Latest Outlook | Previous Outlook or Comparator | Update |
|---|---|---|---|
| Full-year 2026 adjusted diluted EPS | $3.83-$3.93 | $3.73-$3.93 | Lower end raised by $0.10; midpoint raised to $3.88 |
| Full-year 2026 free cash flow | Approximately $450 million | Approximately $450 million | Reaffirmed; versus $445.2 million in 2025 |
| Q4 2026 adjusted diluted EPS | $0.76-$0.86 | $0.67 in Q4 2025 | Midpoint of $0.81 represents 21% growth |
Silgan expects approximately $310 million of capital expenditures in 2026. Management also anticipates earnings and free cash flow growth in 2027, although no quantitative 2027 guidance was provided.
Risks Investors Need to Watch
- Continued volume pressure: Metal Containers volume declined 4% and Custom Containers volume fell 8%. Persistent weakness in soup, food and beverage closures, or other consumer markets could limit organic sales growth and operating leverage.
- Price-cost timing: Dispensing and Specialty Closures faced delayed recovery of manufacturing inflation, freight, and surcharges. Further delays could continue to pressure segment margins.
- Cash conversion: Operating activities used $646.4 million during the first nine months, led by receivables. Meeting the approximately $450 million full-year free cash flow target depends heavily on fourth-quarter working-capital conversion.
- Acquisition and rationalization costs: These costs materially widened the difference between GAAP and adjusted earnings. Continued charges could keep reported profit below the trend indicated by adjusted results.
Summary
Silgan’s Q3 2026 revenue growth came mainly from cost pass-through rather than broad volume expansion. Metal Containers and Custom Containers improved adjusted profitability, helping adjusted EPS rise, but higher rationalization and acquisition-related costs, along with a higher tax rate, reduced GAAP earnings. The next key issues are volume stabilization, recovery of inflation-related costs, fourth-quarter cash conversion, and execution against the narrowed full-year EPS outlook.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles
Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.